Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Slusher

Showing results (91-100 of 670) with videos related to

Pageof 67
Sort By:
Journal of the American Veterinary Medical Association|February 15, 1971
Treatment of Brodie's abscess by means of bone autograftC D Knecht, R Slusher, A J Cawley
Pediatric Research|January 14, 2026
A novel medical device that combines filtered sunlight phototherapy and kangaroo care to treat neonatal jaundice: bench feasibility studyDaniel J John, Stephen C John, Tina Slusher
JAMA Network Open|January 10, 2025
Hemolytic Disease of the Fetus and Newborn-A Need for Management Consensus and More Worldwide RepresentationTina M Slusher, Emmanuela Ambrose, Alexander A Boucher
American Journal of Nephrology|January 1, 1988
Regional citrate anticoagulation for hemodialysis following cardiovascular surgeryJ W Lohr, S Slusher, D A Diederich
Pediatrics|March 1, 2023
Relevance of the 2022 American Academy of Pediatrics Hyperbilirubinemia Guidelines for an LMICTina M Slusher, Isa Abdulkadir, Joshua A Owa
Children (Basel, Switzerland)|July 29, 2025
Bubble NIPPV: Guidelines for UseMounika Muttineni, Vineet Bhandari, Stephen John, et al.
Drug Discovery Today|September 11, 2007
Progress in the discovery and development of glutamate carboxypeptidase II inhibitorsTakashi Tsukamoto, Krystyna M Wozniak, Barbara S Slusher
Synapse (New York, N.Y.)|October 6, 2000
Modulation of behavioral sensitization to cocaine by NAALADase inhibitionT S Shippenberg, W Rea, B S Slusher
ACS Chemical Neuroscience|January 18, 2024
Empirical Analysis of Drug Targets for Nervous System DisordersLouis G Mueller, Barbara S Slusher, Takashi Tsukamoto
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 26, 2013
Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzymeJesse Alt, Marigo Stathis, Camilo Rojas, et al.
Pageof 67

Showing results (91-100 of 670) with videos related to

Sort By:
Pageof 67
Journal of the American Veterinary Medical Association|February 15, 1971
Treatment of Brodie's abscess by means of bone autograftC D Knecht, R Slusher, A J Cawley
Pediatric Research|January 14, 2026
A novel medical device that combines filtered sunlight phototherapy and kangaroo care to treat neonatal jaundice: bench feasibility studyDaniel J John, Stephen C John, Tina Slusher
JAMA Network Open|January 10, 2025
Hemolytic Disease of the Fetus and Newborn-A Need for Management Consensus and More Worldwide RepresentationTina M Slusher, Emmanuela Ambrose, Alexander A Boucher
American Journal of Nephrology|January 1, 1988
Regional citrate anticoagulation for hemodialysis following cardiovascular surgeryJ W Lohr, S Slusher, D A Diederich
Pediatrics|March 1, 2023
Relevance of the 2022 American Academy of Pediatrics Hyperbilirubinemia Guidelines for an LMICTina M Slusher, Isa Abdulkadir, Joshua A Owa
Children (Basel, Switzerland)|July 29, 2025
Bubble NIPPV: Guidelines for UseMounika Muttineni, Vineet Bhandari, Stephen John, et al.
Drug Discovery Today|September 11, 2007
Progress in the discovery and development of glutamate carboxypeptidase II inhibitorsTakashi Tsukamoto, Krystyna M Wozniak, Barbara S Slusher
Synapse (New York, N.Y.)|October 6, 2000
Modulation of behavioral sensitization to cocaine by NAALADase inhibitionT S Shippenberg, W Rea, B S Slusher
ACS Chemical Neuroscience|January 18, 2024
Empirical Analysis of Drug Targets for Nervous System DisordersLouis G Mueller, Barbara S Slusher, Takashi Tsukamoto
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 26, 2013
Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzymeJesse Alt, Marigo Stathis, Camilo Rojas, et al.
Pageof 67